Severe megaloblastic anemia in a patient with advanced lung adenocarcinoma during treatment with erlotinib: a case report and literature review.

Authors:
Yan X; Kong J; Wang J; Wang C; Shen H.

Journal:
BMC Pulm Med

Publication Year: 2024

DOI:
10.1186/s12890-024-02935-9

PMCID:
PMC10919028

PMID:
38448889

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: BMC Pulm Med

Detailed journal information not available.

Publication Details

Subject Category: Respiratory System

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Declarations Ethical approval and consent to participateThis is a case report and not a research report. Ethical approval was not required. All procedures performed were in accordance with the ethical standards of the institutional research committee and with that in the Helsinki Declaration (as revised in 2013). Consent for publicationWritten informed consent was obtained from the patient for publication of this case report and any accompanying images. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Funding Disclosure

Evidence found in paper:

"Funding Not applicable."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025